AMRI and Regeneron executives talk strategies for making money

... making more than just one highly profitable drug, a strategy well underway at the public company headquartered in Tarrytown, New York. Three other Regeneron drugs are poised to hit markets to treat skin diseases, high cholesterol and arthritis. They ...

http://ift.tt/1ulY5DI